Reply To: The “New Normal” for Shul During the Yamim Noraim

The head of infectious diseases at Montefiore in Dr. Liise-anne Pirofsky. She has been in the news regarding her research in the use of antibody-containing plasma to help COVID patients. All I can find that’s relevant to this discussion is quite dated, but here it is: “Having antibodies is not a license to stop the mitigation guidelines and rules that are in effect in many states,” she said. “Having any antibody is not a license today, on April 24, to break with that policy.”